GlassScriptPhysician profile
Philip A Rivera
NPI 1154748531
$4,286.94
in general payments reported to CMS, 2019-2025
13 companies · $836 in 2025
The $836 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $375 · 2021: $100 · 2022: $498 · 2023: $747 · 2024: $1,731 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,991 · Travel and Lodging: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,990.74 |
| Travel and Lodging | $323.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,084.90 | 2021-2025 | Ellipsys Vascular Access System, Abre, Endurant Iis |
| W. L. Gore & Associates, INC. | $787.45 | 2023-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic Vascular, INC. | $375.00 | 2020 | |
| Lemaitre Vascular, INC. | $236.58 | 2025 | Hydro Lemaitre Valvulotome, Restoreflow, Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $222.89 | 2024-2025 | Rotarexs 6 F X 135 Cm, Pristine |
| Penumbra, INC. | $147.36 | 2023 | Penumbra System |
| Ethicon US, LLC | $137.46 | 2025 | Vistaseal, Stratafix, Evarrest |
| Silk Road Medical, INC. | $125.00 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $59.29 | 2023-2025 | Varithena Administration Pack |
| Tactile Systems Technology INC | $44.08 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $25.17 | 2024 | Xarelto |
| Angiodynamics, INC. | $23.28 | 2023 | Alphavac |
| Mimedx Group, INC. | $18.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.